Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

被引:161
作者
Borowsky, AD
Namba, R
Young, LJT
Hunter, KW
Hodgson, JG
Tepper, CG
McGoldrick, ET
Muller, WJ
Cardiff, R
Gregg, JP
机构
[1] Univ Calif Davis, Dept Comparat Med, Ctr Comparat Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Sch Med, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA
[3] NCI, Lab Populat Genet, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
[4] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
[5] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA
[6] McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada
关键词
Akt; breast; breast carcinoma; cell line metastasis; comparative genomic hybridization; ERBB2; gene expression analysis; LY294002; mammary fat pad; mouse mammary tumor virus long terminal repeat; oncogene; orthotopic; phosphatidylinositol; 3; kinase; polyoma middle T; pulmonary metastasis; Sept9; Spp1; osteopontin; Opn; syngeneic; transgenic; tumor transplant;
D O I
10.1007/s10585-005-2908-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two cell lines, Met-1(fvb2) and DB-7(fvb2), with different metastatic potential, were derived from mammary carcinomas in FVB/N-Tg(MMTV-PyVmT) and FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) mice, transplanted into syngeneic FVB/N hosts and characterized. The lines maintain a stable morphological and biological phenotype after multiple rounds of in vitro culture and in vivo transplantation. The Met-1(fvb2) line derived from a FVB/N-Tg(MMTV-PyVmT) tumor exhibits invasive growth and 100% metastases when transplanted into the females FVB/N mammary fat pad. The DB-7(fvb2) line derived from the FVB/N-Tg(MMTV-PyVmT(Y315F/Y322F)) with a "double base" modification at Y315F/Y322F exhibits more rapid growth when transplanted into the mammary fat pad, but a lower rate of metastasis (17%). The Met1(fvb2) cells show high activation of AKT, while DB-7(fvb2) cells show very low levels of AKT activation. The DNA content and gene expression levels of both cell lines are stable over multiple generations. Therefore, these two cell lines provide a stable, reproducible resource for the study of metastasis modulators, AKT molecular pathway interactions, and gene target and marker discovery.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 38 条
  • [1] Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours
    Baribault, H
    WilsonHeiner, M
    Muller, W
    Penner, J
    Bakhiet, N
    [J]. TRANSGENIC RESEARCH, 1997, 6 (06) : 359 - 367
  • [2] Basu GD, 2004, MOL CANCER RES, V2, P632
  • [3] Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.3.CO
  • [4] 2-S
  • [5] The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting
    Cardiff, RD
    Anver, MR
    Gusterson, BA
    Hennighausen, L
    Jensen, RA
    Merino, MJ
    Rehm, S
    Russo, J
    Tavassoli, FA
    Wakefield, LM
    Ward, JM
    Green, JE
    [J]. ONCOGENE, 2000, 19 (08) : 968 - 988
  • [6] Cheung ATW, 1997, INT J ONCOL, V11, P69
  • [7] A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers
    Cozma, D
    Lukes, L
    Rouse, J
    Qiu, TH
    Liu, ET
    Hunter, KW
    [J]. GENOME RESEARCH, 2002, 12 (06) : 969 - 975
  • [8] Polyoma virus middle T antigen and its role in identifying cancer-related molecules
    Dilworth, SM
    [J]. NATURE REVIEWS CANCER, 2002, 2 (12) : 951 - 956
  • [9] ISOLATION AND CULTURE OF HEPATIC LIPOCYTES, KUPFFER CELLS, AND SINUSOIDAL ENDOTHELIAL-CELLS BY DENSITY GRADIENT CENTRIFUGATION WITH STRACTAN
    FRIEDMAN, SL
    ROLL, FJ
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 161 (01) : 207 - 218
  • [10] Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5′ MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoter
    Graham, RA
    Morris, JR
    Cohen, EP
    Taylor-Papadimitriou, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (03) : 382 - 387